株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

欧州の人工血管市場

European Markets for Prosthetic Vascular Grafts

発行 Medtech Insight 商品コード 278602
出版日 ページ情報 英文 182 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。
Back to Top
欧州の人工血管市場 European Markets for Prosthetic Vascular Grafts
出版日: 2013年07月31日 ページ情報: 英文 182 Pages
概要

欧州における代用血管の売り上げは、2012年に8億6,500万米ドルとなりました。今後はCAGR8.1%で成長し、2017年におよそ13億米ドルへ達すると予測されています。

当レポートでは、欧州の代用血管市場における製品、技術、市場の現況と予測、競合企業および機会を分析しており、主要疾患別の分析、心疾患管理、および主要企業のプロファイルなどをまとめ、概略下記の構成でお届けいたします。

エグゼクティブサマリー

第1章 主な心疾患/障害の概要

  • 心疾患/障害
  • 心疾患管理オプション

第2章 欧州の人工血管市場

  • 人工血管のアプリケーション
  • 人工血管の分類
  • 人工血管市場

第3章 企業プロファイル

  • Atrium Medical Corporation/Getinge Group AB
  • C.R. Bard, Inc.
  • Cook Group, Inc.
  • W.L. Gore & Associates, Inc.
  • Maquet Vascular Interventions/Getinge Group AB
  • Medtronic, Inc.
  • Vascutek LTD/Terumo Corporation
目次
Product Code: A270

The number of patients in Europe receiving prosthetic grafts for aneurysm repair, coronary and peripheral vessel reconstruction, and hemodialysis access is expected to increase over the forecast period covered by this report due to the prevalence of both diabetes and cardiovascular disease in the region. In 2012, European sales of prosthetic vascular grafts totaled approximately $865 million; of this, endovascular stent-grafts for aortic aneurysm repair accounted for nearly 87% of sales, followed by peripheral vascular grafts with 10%, hemodialysis access grafts with 3%, and small-diameter CABG grafts with less than 1%. Over the forecast period covered by this report, total sales are expected to increase at a compound annual rate of 8.1%, reaching nearly $1.3 billion in the year 2017. Growth will be driven by technological advancements, population demographics, the growing prevalence of diabetes, and an increase in the number of interventional vascular surgeons in Europe.

This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the European prosthetic vascular grafts market. Major topics covered by this report include an overview of selected cardiovascular diseases and disorders (e.g., aneurysm, coronary heart disease, diabetes, hypertension, and stroke); cardiovascular disease management options; and a discussion of products, competitors, and forecast markets for prosthetic vascular graft segments including endovascular stent-grafts for aortic aneurysm repair, hemodialysis access grafts, peripheral vascular grafts, and small-diameter CABG grafts.

Table of Contents

EXECUTIVE SUMMARY

  • i. Prosthetic Vascular Grafts
  • a. Applications
  • b. Product Categories
  • c Hemodialysis Access Grafts
  • d. Endovascular Stent-Grafts for Aortic Aneurysm Repair
  • e. Peripheral Vascular Grafts
  • f. Small-Diameter Coronary Artery Bypass Grafts
  • g. Combined Market Analysis
  • Exhibit ES-1: Europe, Hemodialysis Access Grafts, Market Forecast, by Country, 2012-2017
  • Exhibit ES-2: Europe, Endovascular Stent-Grafts for Abdominal and Thoracic Aortic Aneurysm Repair Market Forecast, by Country, 2012-2017
  • Exhibit ES-3: Europe, Peripheral Vascular Grafts, Market Forecast, by Country, 2012-2017
  • Exhibit ES-4: Europe, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, by Country, 2012-2017
  • Exhibit ES-5: Europe, Prosthetic Vascular Grafts, Combined Market Forecast, by Country, 2012-2017

1. OVERVIEW OF SELECTED CARDIOVASCULAR DISEASES/DISORDERS

  • 1.1. Cardiovascular Diseases/Disorders
    • 1.1.1. Coronary Heart Disease
      • 1.1.1.1. Atherosclerosis
        • 1.1.1.1.1. Description
        • 1.1.1.1.2. Statistics
      • 1.1.1.2. Angina Pectoris
        • 1.1.1.2.1. Description
        • 1.1.1.2.2. Statistics
      • 1.1.1.3. Myocardial Infarction
        • 1.1.1.3.1. Description
        • 1.1.1.3.2. Statistics
    • 1.1.2. Hypertension
      • 1.1.2.1. Description
      • 1.1.2.1. Statistics
    • 1.1.3. Aneurysm
      • 1.1.3.1. Description
      • 1.1.3.2. Statistics
    • 1.1.4. Stroke
      • 1.1.4.1. Description
      • 1.1.4.2. Statistics
    • 1.1.5. Diabetes
      • 1.1.5.1. Description
      • 1.1.5.2. Statistics
  • 1.2. Cardiovascular Disease Management Options
    • 1.2.1. Medical Management
      • 1.2.1.1. Lifestyle Changes
        • 1.2.1.1.1. Dietary Modification
        • 1.2.1.1.2. Smoking Cessation
      • 1.2.1.2. Pharmaceuticals
        • 1.2.1.2.1. Anticoagulants and Antiplatelet Drugs
        • 1.2.1.2.2. Lipid-Lowering Drugs
        • 1.2.1.2.3. Antihypertensive Drugs
        • 1.2.1.2.4. Nitroglycerin Preparations
    • 1.2.2. Intracoronary Heart Disease Diagnosis
      • 1.2.2.1. Coronary Angiography
        • 1.2.2.1.1. Description
        • 1.2.2.1.2. Statistics
    • 1.2.3. Coronary Artery Disease Treatment
      • 1.2.3.1. Coronary Artery Bypass Graft Surgery
        • 1.2.3.1.1. Less Invasive Coronary Artery Bypass Graft Techniques
      • 1.2.3.2. Percutaneous Transluminal Coronary Angioplasty and Coronary Stenting
      • 1.2.3.3. Peripheral Percutaneous Revascularization Techniques
        • 1.2.3.3.1. Percutaneous Transluminal Angioplasty and Peripheral Stenting
        • 1.2.3.3.2. Peripheral Atherectomy
        • 1.2.3.3.3. Peripheral Femoropopliteal Stenting
  • Exhibit 1-1: Number of Deaths due to Cardiovascular Diseases/Disorders, by Gender
  • Exhibit 1-2: 2008, Prevalence of Hypercholesterolemia, by Gender
  • Exhibit 1-3: Standard Angina Pectoris Classification
  • Exhibit 1-4: 30-Day Case Fatality Rates Following Hospital Admission for Acute Myocardial Infarction, Selected European Countries
  • Exhibit 1-5: 2008, Prevalence of Hypertension, by Gender
  • Exhibit 1-6: Stroke, Hospital Discharge Rates, 2000 and 2009
  • Exhibit 1-7: 2008, Prevalence of Elevated Blood Glucose, by Gender
  • Exhibit 1-8: 2007, Daily Per-Person Consumption of Fats, Fruits, and Vegetables
  • Exhibit 1-9: Tobacco Smoking Rate, by Gender
  • Exhibit 1-10: 2006/2007, Medication at Discharge for Patients with Coronary Heart Disease, Selected European Countries
  • Exhibit 1-11: 2007, Cardiac Catheterization Laboratories and Coronary Angiography Procedures, Selected European Countries
  • Exhibit 1-12: 2010, Coronary Artery Bypass Graft Surgery, Selected European Countries, by Type
  • Exhibit 1-13: 2010, Percutaneous Coronary Intervention/Stenting Procedures, Selected European Countries, by Type
  • Exhibit 1-14: 2010, Peripheral Vascular Disease Treatment Procedures, Selected European Countries, by Type

2. THE EUROPEAN PROSTHETIC VASCULAR GRAFTS MARKET

  • 2.1. Prosthetic Vascular Grafting Applications
    • 2.1.1. Aneurysm
    • 2.1.2. Kidney Failure
    • 2.1.3. Vascular Occlusion
  • 2.2. Prosthetic Vascular Graft Categorization
    • 2.2.1. Categorization by Graft Diameter
      • 2.2.1.1. Large-Diameter Grafts
      • 2.2.1.2. Medium-Diameter Grafts
      • 2.2.1.3. Small-Diameter Grafts
    • 2.2.2. Categorization by Graft Material
      • 2.2.2.1. Polyester
      • 2.2.2.2. Polytetrafluoroethylene
      • 2.2.2.3. Polyurethane
      • 2.2.2.4. Biological
        • 2.2.2.4.1. Human Saphenous and Umbilical Veins
        • 2.2.2.4.2. Tissue-Engineered Materials
    • 2.2.3. Endovascular Stent-Grafts
      • 2.2.3.1. Performance Requirements
      • 2.2.3.2. Configurations
      • 2.2.3.3. Endovascular Stent-Graft-Related Complications
  • 2.3. Prosthetic Vascular Grafts Market
    • 2.3.1. Market Drivers and Limiters
    • 2.3.2. Hemodialysis Access Grafts
      • 2.3.2.1. Market Forecast
      • 2.3.2.2. Competitive Analysis
    • 2.3.3. Endovascular Stent-Graft Systems for Aortic Aneurysm Repair
      • 2.3.3.1. Market Forecast
      • 2.3.3.2. Competitive Analysis
    • 2.3.4. Peripheral Vascular Grafts
      • 2.3.4.1. Market Forecast
      • 2.3.4.2. Competitive Analysis
    • 2.3.5. Small-Diameter Coronary Artery Bypass Grafts
      • 2.3.5.1. Market Forecast
      • 2.3.5.2. Competitive Analysis
    • 2.3.6. Combined Market Forecast
  • Exhibit 2-1: Indications for the Use of Prosthetic Vascular Grafts
  • Exhibit 2-2: Interventions for the Treatment of Peripheral Vascular Occlusions
  • Exhibit 2-3: Design Criteria for Synthetic Vascular Grafts
  • Exhibit 2-4: Applications for Prosthetic Vascular Grafts, by Diameter
  • Exhibit 2-5: 2013, Selected Polyester Vascular Grafts
  • Exhibit 2-6: 2013, Selected Polytetrafluoroethylene Vascular Grafts
  • Exhibit 2-7: 2013, Selected Polyurethane Vascular Grafts
  • Exhibit 2-8: Design Specifications for Endovascular Stent-Graft Systems
  • Exhibit 2-9: Complications Associated with the Use of Endovascular Stent-Grafts for Abdominal Aortic Aneurysm Repair
  • Exhibit 2-10: 2013, Selected Endovascular Stent-Grafts for Aortic Aneurysm Repair
  • Exhibit 2-11: Europe, Hemodialysis Access Grafts, Market Forecast, by Country, 2012-2017
  • Exhibit 2-12: 2012, Europe, Hemodialysis Access Grafts Market, Share by Supplier
  • Exhibit 2-13: Europe, Endovascular Stent-Grafts for Abdominal and Thoracic Aortic Aneurysm Repair, Market Forecast, by Country, 2012-2017
  • Exhibit 2-14: 2012, Europe, Endovascular Abdominal Aortic Aneurysm Stent-Grafts Market, Share by Supplier
  • Exhibit 2-15: 2012, Europe, Endovascular Thoracic Aortic Aneurysm Stent-Grafts Market, Share by Supplier
  • Exhibit 2-16: Europe, Peripheral Vascular Grafts, Market Forecast, by Country, 2012-2017
  • Exhibit 2-17: 2012, Europe, Peripheral Vascular Grafts Market, Share by Supplier
  • Exhibit 2-18: Europe, Small-Diameter Coronary Artery Bypass Grafts, Market Forecast, by Country, 2012-2017
  • Exhibit 2-19: 2012, Europe, Small-Diameter Coronary Artery Bypass Grafts Market, Share by Supplier
  • Exhibit 2-20: Europe, Prosthetic Vascular Grafts, Combined Market Forecast, by Country, 2012-2017

3. COMPANY PROFILES

  • 3.1. Atrium Medical Corporation/Getinge Group AB
  • 3.2. C.R. Bard, Inc.
  • 3.3. Cook Group, Inc.
  • 3.4. W.L. Gore & Associates, Inc.
  • 3.5. Maquet Vascular Interventions/Getinge Group AB
  • 3.6. Medtronic, Inc.
  • 3.7. Vascutek LTD/Terumo Corporation
Back to Top